Onglyza (saxagliptin) is a type-2 diabetes treatment drug, belonging to a group of diabetes medications called incretin mimetics, which work by imitating incretin hormones, which are vital to diabetes patients as they naturally increase the body’s insulin production.
Ongylza was released in 2009 as a joint effort by AstraZeneca and Bristol-Myers Squibb and became a top selling drug by 2011.
Unfortunately, this drug has been linked to a variety of severe complications, with pancreatic cancer and other problems related to the pancreas being some of the most prevalent concerns.
Overview of Onglyza Side Effects
Recent studies have suggested that side effects of Onglyza side effects pancreatitis in many patients, with more serious cases forming into pancreatic cancer. One of the most recent inquiries was published in the medical journal Diabetes in March 2013, where researchers conducted pancreas examinations on 20 deceased diabetes patients.
Eight of these patients were prescribed incretin mimetic diabetes medications, including Onglyza, and were found to have enlarged pancreases. In these cases, the patients exhibited a significantly higher number of beta cells in their pancreases along with significant pre-cancerous cell formation.
In February 2013, researchers at Johns Hopkins found that diabetic patients hospitalized for pancreatitis were twice as likely to have been prescribed an incretin mimetic diabetes medication.
The Diabetes study was published after the FDA released a public warning regarding the alleged link between Onglyza and pancreatic cancer. Patients who start experiencing an adverse symptoms while taking Onglyza are encouraged to consult their physician as soon as possible.
Early symptoms of pancreatic cancer are typically very mild, making latent diagnoses common. Onglyza patients who start experiencing abdominal pain, yellowing skin or eyes, diarrhea, dark urine, and light colored stool should seek medical attention.
Since Onglyza works by signaling the body to create more insulin, the pancreas is directly stimulated. It has been noted that Onglyza may be causing inflammation in the pancreas, which increases the risks of cancer development.
Additionally, cells that are produced in the pancreas could already be pre-cancerous, leaving dangerous possibilities for even benign tumors. Pancreatic cancer is one of the most devastating cancer forms, with long-term prognosis survival rates being very low. Fewer than 5% of patients diagnosed with pancreatic cancer survive beyond five years.
Even for those who survive pancreatic cancer, numerous surgeries are often required with patients being forced to live with lifelong complications. Many Onglyza patients who have suffered pancreatic cancer and other Onglyza side effects, complained that AstraZeneca and Bristol-Myers did not fully disclose the risks associated with their product.
Legal Help For Onglyza Patients
Specialized legal experts are calling on former or current Onglyza patients to consider taking legal action against manufacturing companies AstraZeneca and Bristol-Myers.
Patients who have suffered severe Onglyza side effects, like pancreatic cancer, may be able to seek compensation from the pharmaceutical companies that failed to protect them against drug injuries.
In general, Onglyza lawsuits are filed individually by each plaintiff and are not class actions.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Onglyza lawsuit or Ongylyza class action lawsuit is best for you. Hurry — statutes of limitations may apply.
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2015 Top Class Actions® LLC
Various Trademarks held by their respective owners
Get Help – It’s Free
Join a Free Onglyza Lawsuit Investigation
If you or a loved one were injured from Onglyza side effects such as heart failure, thyroid cancer or pancreatic cancer, you may have a legal claim. See if you qualify to pursue compensation and join a free Onglyza lawsuit investigation by submitting your information for a free case evaluation.
An attorney will contact you if you qualify to discuss the details of your potential case.
- First Name*
- Last Name*
- Street Address*
- Apt. #
- City*
- State*
AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific
- Zip Code*
- Phone*
- Email*
- Which diabetes drug did you/your loved one take?*
- Onglyza
- Kombiglyze XR
- Other (please describe in additional details box below)
- What year did you/your loved one start taking this medication?*
- Which of the following problems did you/your loved one experience after taking this medication?*
-
Heart Failure
-
Heart Attack
-
Pancreatic Cancer
-
Thyroid Cancer
-
Death
-
Other (please describe in the additional details box below)
-
- What year were you/your loved one diagnosed with one or more of these problems?*
- ¿Necesita un orador español?
- Yes
- No
- Please enter any additional details you would like the staff reviewing your submission to know.*
- I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared.*
-
Yes
-
-
if(typeof gf_global == ‘undefined’) var gf_global = {“gf_currency_config”:{“name”:”U.S. Dollar”,”symbol_left”:”$”,”symbol_right”:””,”symbol_padding”:””,”thousand_separator”:”,”,”decimal_separator”:”.”,”decimals”:2},”base_url”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms”,”number_formats”:[],”spinnerUrl”:”http:\/\/topclassactions.com\/wp-content\/plugins\/gravityforms\/images\/spinner.gif”};jQuery(document).bind(‘gform_post_render’, function(event, formId, currentPage){if(formId == 141) {gformInitChosenFields(‘#input_141_5′,’No results matched’);if(!/(android)/i.test(navigator.userAgent)){jQuery(‘#input_141_7’).mask(‘(999) 999-9999’).bind(‘keypress’, function(e){if(e.which == 13){jQuery(this).blur();} } );}} } );jQuery(document).bind(‘gform_post_conditional_logic’, function(event, formId, fields, isInit){gformInitChosenFields(‘#input_141_5′,’No results matched’);} ); jQuery(document).ready(function(){jQuery(document).trigger(‘gform_post_render’, [141, 1]) } );
The post Diabetes Medication Onglyza Linked to Pancreatic Cancer appeared first on Top Class Actions.
No comments:
Post a Comment